Figure 1.
TP53 defects in the analyzed cohort. (A) Composition of TP53 defects. (B) TP53 mutations in 141 patients with CLL, in order according the highest VAF. Black, highest mutation VAF; white, cumulative mutation VAF.
TP53 defects in the analyzed cohort. (A) Composition of TP53 defects. (B) TP53 mutations in 141 patients with CLL, in order according the highest VAF. Black, highest mutation VAF; white, cumulative mutation VAF.